Improved insulin enteral delivery using water-in-oil-in-water multiple emulsion incorporating highly purified docosahexaenoic acid

S.T.P. Pharma Sciences

Volumn 13, Issue 4, 2003, Pages 231-235

  Onuki, Y ^a   Morishita, M ^a   Watanabe, H ^a   Chiba, Y ^b   Tokiwa, S ^b   Takayama, K ^a   Nagai, T ^a  

^a HOSHI UNIVERSITY   (Japan)

^b Nippon Suisan Kaisya Ltd   (Japan)

Author keywords

Docosahexaenoic acid; Emulsion; Glyceride; Insulin; Intestinal absorption; Reversibility

Indexed keywords

DECANOIC ACID; DOCOSAHEXAENOIC ACID; INSULIN; LAURIC ACID; MEDIUM CHAIN FATTY ACID; MONOACYLGLYCEROL; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; INTESTINE ABSORPTION; MALE; NONHUMAN; RAT; RECTUM; UPPER GASTROINTESTINAL TRACT;

EID: 0242318942     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. SUZUKI A., MORISHITA M., KAJITA M., TAKAYAMA K., ISOWA K., CHIBA Y., TOKIWA S., NAGAI T. - Enhanced colonic and rectal absorption of insulin using a multiple emulsion containing eicosapentaenoic acid and docosahexaenoic acid. - J. Pharm. Sci., 87, 1196-202, 1998.
2. ONUKI Y., MORISHITA M., TAKAYAMA K., TOKIWA S., CHIBA Y., ISOWA K., NAGAI T. - In vivo effects of highly purified docosahexaenoic acid on rectal insulin absorption.- Int. J. Pharm., 198, 147-156, 2000.
3. MORISHITA M., KAJITA M., SUZUKI A., TAKAYAMA K., CHIBA Y., TOKIWA S., NAGAI T. - The dose-related hypoglycemic effects of insulin emulsions incorporating highly purified EPA and DHA. - Int. J. Pharm, 201, 175-185, 2000.
4. MURANISHI S. - Absorption enhancers. - Crit. Rev. Ther. Drug Syst., 7, 1-33, 1990.
5. KAJITA M., MORISHITA M., TAKAYAMA K., CHIBA Y., TOKIWA S., NAGAI T. - Enhanced enteral bioavailability of vancomycin using water-in-oil-in-water multiple emulsion incorporating highly purified unsaturated fatty acid. - J. Pharm. Sci., 89, 1243-1252, 2000.
6. TRIER J.S., MADARA J.L. - In: Physiology of the Gastrointestinal Tract, L.R. Johnson Ed., Raven Press, vol. 2, pp. 925-962, 1981.
7. LINDMARK T., KIMURA Y., ARTURSSON P. - Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. - J. Pharmacol. Exp. Ther., 284, 362-369, 1998.
8. SAWADA T., OGAWA T., TOMITA M., HAYASHI M., AWAZU S. - Role of paracellular pathway in nonelectrolyte permeation across rat colon epithelium enhanced by sodium caprate and sodium caprylate. - Pharm. Res., 8, 1365-71, 1991.
9. SEKINE M., SASAHARA K., KOJIMA T., HASEGAWA K., OKADA R. - Improvement of bioavailability of poorly intestinally absorbed drugs from medium-chain glyceride base. Enhancement of the rectal absorption of cefmetazole sodium in rabbits. - Chem. Pharm. Bull., 32, 4189-4192, 1984.
10. MATTSON F.H., BECK L.H. - The specificity of pancreatic lipase for primary hydroxyl group of glycerides. - J. Biol. Chem., 219, 735-740, 1956.
11. LEE V.H., YAMAMOTO A. - Penetration and enzymic barriers to peptide and protein absorption. - Adv. Drug Deliv Rev., 4, 171-207, 1990.
12. YAMAMOTO A., MURANISHI S. - Rectal drug delivery systems improvement of rectal peptide absorption by absorption enhancers, protease inhibitors and chemical modification. - Adv. Drug Deliv Rev., 28, 275-299, 1997.
13. LEE V.H., YAMAMOTO A., KOMPELLA U.B. - Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. - Crit. Rev. Ther. Drug Carrier Syst., 8, 91-192, 1991.
14. YAMAMOTO A., TANIGUCHI T., RIKYUU K., FUJITA T., MURAKAMI M., MURANISHI S. - Effect of various protease inhibitors on the intestinal absorption and degradation of insulin in rats - Pharm. Res., 11, 1496-1500, 1994.
15. MURANISHI S. - Modification of intestinal absorption of drugs by lipoidal adjuvants. - Pharm. Res., 2, 108-118, 1985.
16. O'REILLY J.R., CORRIGAN O.I., O'DRISCOLL C.M. - The effect of mixed micellar systems, bile salt/fatty acids, on the solubility and intestinal absorption of clofazimine (B663) in the anaesthetized rat. - Int. J. Pharm., 109, 147-154, 1994.
17. LEWIN M.R., El MASSRI S.H. CLARK C.G. - Effect of bile salts on mucus secretion in the dog colon. - Eur. Surg. Res., 11, 392-398, 1979.
18. YAMASHITA S., MASADA M., NADAI T., KIMURA T. - Effect of adjuvants on charge-selective permeability and electrical resistance of rat jejunal membrane. - J. Pharm. Sci., 79, 579-583, 1990.
19. O'REILLY J.R., CORRIGAN O.I., O'DRISCOLL C.M. - The effect of simple micellar systems on the solubility and intestinal absorption of clofazimine (B663) in the anaesthetized rat. - Int. J. Pharm., 109, 137-146, 1994.
20. WERNER U., KISSEL T., REERS M. - Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC220) in a human intestinal cell line (CaCo-2). - Pharm. Res., 13, 1219-1227, 1996.
21. LANE M.E., O'DRISCOLL C.M., CORRIGAN O.I. - The relationship between rat intestinal permeability and hydrophilic probe size. - Pharm. Res., 13, 1552-1556, 1996.
22. SWENSON E.S., MILISEN W.B., CURATOLO W. - Intestinal permeability enhancement: efficacy, acute local toxicity and reversibility. - Pharm. Res., 11, 1132-1142, 1994.